PRESCRIBING · PART D · 2024
Total Rx claims
3,174
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
38
Brand share
30.5%
Top prescribed drugs
Levetiracetam479 claims
Lacosamide343 claims
Lamotrigine252 claims
Cenobamate238 claims
Brivaracetam155 claims
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
80.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
CROSS-REFERENCE